Orbis Investment Management Acquires 4.99% Stake in Genmab A/S

Deal Summary

Orbis Investment Management Limited announced that it now controls 3,112,476 shares of Genmab A/S, representing 4.99% of the company's share capital, as of June 12 2026. The disclosure was made in a major shareholder announcement filed by Genmab, confirming the completed stake acquisition.